• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预算约束型医疗体系中的“健康”之外的价值。

Values Beyond "Health" in Budget-Constrained Healthcare Systems.

机构信息

Department of Economics, University of Rochester, Rochester, NY, USA; Department of Public Health Sciences, University of Rochester, Rochester, NY, USA; Department of Political Science, University of Rochester, Rochester, NY, USA.

出版信息

Value Health. 2024 Jul;27(7):830-836. doi: 10.1016/j.jval.2024.02.005. Epub 2024 Feb 22.

DOI:10.1016/j.jval.2024.02.005
PMID:38401798
Abstract

OBJECTIVES

Most current methods to value healthcare treatments only incorporate measures such as quality-adjusted life-years, combining gains in health-related quality of life and life expectancy in specific ways. Failure of these methods to recognize other dimensions of value has led to calls for methods to include additional values that are associated with the healthcare treatments but not captured directly by quality-adjusted life-years. This article seeks to provide methodologically sound ways to incorporate additional health-related outcomes, focusing on budget-constrained healthcare systems, in which using standard welfare economics methods are often eschewed.

METHODS

The analysis develops standard extra-welfarist approaches to maximizing aggregate health, subject to fixed-budget constraints, using Lagrange multiplier methods. Then, additional valuable health-related outcomes, eg, reduced caregiver burden, real option value, and market- and non-market productivity are introduced. The article also introduces a social welfare function approach to illuminate how disability, disease severity and other equity-related issues can be incorporated into complete welfare measures.

RESULTS

Resulting analysis, fully developed in an Appendix in Supplemental Materials found at https://doi.org/10.1016/j.jval.2024.02.005 and summarized in the main text, show that understanding how average and marginal healthcare costs increase with output and how health augments "additional values" provides ways to assess willingness to pay for them in these fixed-budget situations.

CONCLUSIONS

In budget-constrained healthcare systems, only from actual budget allocations can values both of health itself and "additional values" be inferred. These methods, combined with methodologically sound social welfare functions, demonstrate how to move from "health" to "welfare" in measuring the value of increased healthcare use.

摘要

目的

目前大多数评估医疗保健治疗方法的方法仅纳入了质量调整生命年等措施,以特定方式综合了健康相关生活质量和预期寿命的提高。这些方法未能认识到其他价值维度,导致呼吁采用其他方法来纳入与医疗保健治疗相关但无法直接通过质量调整生命年来衡量的附加价值。本文旨在提供将其他健康相关结果纳入其中的方法,重点是在预算受限的医疗保健系统中,因为在这些系统中,通常避免使用标准福利经济学方法。

方法

分析采用拉格朗日乘数法,针对固定预算约束,制定了最大化总健康的标准额外福利主义方法。然后,引入了额外有价值的健康相关结果,例如减少护理人员负担、实物期权价值以及市场和非市场生产力。本文还介绍了一种社会福利函数方法,阐明如何将残疾、疾病严重程度和其他与公平相关的问题纳入全面福利衡量标准。

结果

在补充材料中可以找到完整的分析结果(网址为 https://doi.org/10.1016/j.jval.2024.02.005),并在正文中进行了总结。分析结果表明,理解平均和边际医疗保健成本如何随产出增加,以及健康如何增强“附加价值”,为在这些固定预算情况下评估对其的支付意愿提供了方法。

结论

在预算受限的医疗保健系统中,只有通过实际预算分配,才能推断出健康本身和“附加价值”的价值。这些方法与方法合理的社会福利函数相结合,展示了如何在衡量增加医疗保健使用的价值时,从“健康”过渡到“福利”。

相似文献

1
Values Beyond "Health" in Budget-Constrained Healthcare Systems.预算约束型医疗体系中的“健康”之外的价值。
Value Health. 2024 Jul;27(7):830-836. doi: 10.1016/j.jval.2024.02.005. Epub 2024 Feb 22.
2
On the (Near) Equivalence of Welfarist and Extra-Welfarist Methods to Value Healthcare With Implications for Assessing Equity.从福利主义和超福利主义方法评估医疗保健价值的(近)等价性及其对公平性评估的影响。
Value Health. 2023 Nov;26(11):1601-1607. doi: 10.1016/j.jval.2023.08.001. Epub 2023 Aug 18.
3
Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?评估医疗保健项目的收益与成本:超福利主义中的“额外”因素何在?
Soc Sci Med. 2003 Mar;56(5):1121-33. doi: 10.1016/s0277-9536(02)00101-6.
4
Axiomatic foundations for cost-effectiveness analysis.成本效益分析的公理化基础。
Health Econ. 2013 Dec;22(12):1405-16. doi: 10.1002/hec.2889. Epub 2013 Feb 26.
5
Capabilities as menus: a non-welfarist basis for QALY evaluation.能力作为菜单:一种非功利主义的 QALY 评估基础。
J Health Econ. 2013 Jan;32(1):128-37. doi: 10.1016/j.jhealeco.2012.10.004. Epub 2012 Oct 30.
6
Welfare economics and cost-utility analysis.福利经济学与成本效用分析。
Dev Health Econ Public Policy. 1992;1:143-57. doi: 10.1007/978-94-011-2392-1_7.
7
Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4].目标、预算、阈值与机会成本——一种卫生经济学方法:一份药物经济学与结果研究协会(ISPOR)特别工作组报告[4]
Value Health. 2018 Feb;21(2):140-145. doi: 10.1016/j.jval.2017.12.008.
8
Anti-social welfare functions: a reply to Hansen et al.反社会福利函数:对汉森等人的回应
J Health Econ. 2004 Sep;23(5):899-905. doi: 10.1016/j.jhealeco.2004.01.001.
9
Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.鞘内药物输送系统治疗癌症疼痛:一项卫生技术评估。
Ont Health Technol Assess Ser. 2024 Jan 11;24(2):1-162. eCollection 2024.
10
Cost Effectiveness of Introducing Etonorgestrel Contraceptive Implant into India's Current Family Welfare Programme.将依托孕烯避孕植入剂引入印度现行家庭福利计划的成本效益
Appl Health Econ Health Policy. 2021 Mar;19(2):267-277. doi: 10.1007/s40258-020-00605-5.